ALTEROLA BIOTECH INC. Quarterly Debt-to-equity in % from Q1 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Alterola Biotech Inc. quarterly Debt-to-equity history and growth rate from Q1 2019 to Q3 2024.
  • Alterola Biotech Inc. Debt-to-equity for the quarter ending September 30, 2024 was -143 %, a 542% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -143 -175 -542% Sep 30, 2024
Q2 2024 -126 -145 -741% Jun 30, 2024
Q1 2024 138 +122 +739% Mar 31, 2024
Q4 2023 51.3 +37.8 +279% Dec 31, 2023
Q3 2023 32.4 +16.1 +98.4% Sep 30, 2023
Q2 2023 19.6 -5.22 -21% Jun 30, 2023
Q1 2023 16.5 -40.3 -71% Mar 31, 2023
Q4 2022 13.5 +144 Dec 31, 2022
Q3 2022 16.3 +130 Sep 30, 2022
Q2 2022 24.9 +133 Jun 30, 2022
Q1 2022 56.8 +159 Mar 31, 2022
Q4 2021 -130 -25.4 -24.2% Dec 31, 2021
Q3 2021 -113 -7.63 -7.21% Sep 30, 2021
Q2 2021 -108 -1.8 -1.69% Jun 30, 2021
Q1 2021 -103 +4.82 +4.48% Mar 31, 2021
Q4 2020 -105 +3.96 +3.64% Dec 31, 2020
Q3 2020 -106 +6.03 +5.39% Sep 30, 2020
Q2 2020 -107 +18 +14.4% Jun 30, 2020
Q1 2020 -108 +55.4 +34% Mar 31, 2020
Q4 2019 -109 Dec 31, 2019
Q3 2019 -112 Sep 30, 2019
Q2 2019 -124 Jun 30, 2019
Q1 2019 -163 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.